94 related articles for article (PubMed ID: 30173004)
1. Clinical characteristics and survival of patients with multiple metachronous esophageal tumor.
Mukhtar F; Bubu OM; Hung N L
Cancer Treat Res Commun; 2018; 17():13-17. PubMed ID: 30173004
[TBL] [Abstract][Full Text] [Related]
2. Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study.
Saad AM; Al-Husseini MJ; Elgebaly A; Aboshady OA; Salahia S; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2018 Apr; 12(4):417-423. PubMed ID: 29316808
[TBL] [Abstract][Full Text] [Related]
3. Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome.
Natsugoe S; Matsumoto M; Okumura H; Ishigami S; Uenosono Y; Owaki T; Takao S; Aikou T
World J Surg; 2005 Jan; 29(1):46-9. PubMed ID: 15592914
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary Resection for Second Lung Cancer After Pneumonectomy: A Population-Based Study.
Ayub A; Rehmani SS; Al-Ayoubi AM; Raad W; Flores RM; Bhora FY
Ann Thorac Surg; 2017 Oct; 104(4):1131-1137. PubMed ID: 28709663
[TBL] [Abstract][Full Text] [Related]
5. Risk of metachronous recurrence after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
Uno K; Koike T; Kusaka G; Takahashi Y; Ara N; Shimosegawa T
Dis Esophagus; 2017 Jun; 30(6):1-8. PubMed ID: 28475742
[TBL] [Abstract][Full Text] [Related]
6. Impact of second primary esophageal or lung cancer on survival of patients with head and neck cancer.
Chen MC; Huang WC; Chan CH; Chen PT; Lee KD
Oral Oncol; 2010 Apr; 46(4):249-54. PubMed ID: 20138797
[TBL] [Abstract][Full Text] [Related]
7. Safety and benefit of curative surgical resection for esophageal squamous cell cancer associated with multiple primary cancers.
Otowa Y; Nakamura T; Takiguchi G; Yamamoto M; Kanaji S; Imanishi T; Oshikiri T; Suzuki S; Tanaka K; Kakeji Y
Eur J Surg Oncol; 2016 Mar; 42(3):407-11. PubMed ID: 26733367
[TBL] [Abstract][Full Text] [Related]
8. Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men.
Fosså SD; Chen J; Schonfeld SJ; McGlynn KA; McMaster ML; Gail MH; Travis LB
J Natl Cancer Inst; 2005 Jul; 97(14):1056-66. PubMed ID: 16030303
[TBL] [Abstract][Full Text] [Related]
9. A Population-Based Examination of the Surgical Outcomes for Patients with Esophageal Sarcoma.
Wu GX; Ituarte PH; Paz IB; Kim J; Raz DJ; Kim JY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1310-7. PubMed ID: 26310279
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of metachronous colorectal tumors.
Rennert G; Robinson E; Rennert HS; Neugut AI
Int J Cancer; 1995 Mar; 60(6):743-7. PubMed ID: 7896438
[TBL] [Abstract][Full Text] [Related]
12. Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014.
Pan Y; Lu L; Chen J; Zhong Y; Dai Z
J Orthop Surg Res; 2018 Apr; 13(1):76. PubMed ID: 29625617
[TBL] [Abstract][Full Text] [Related]
13. A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data.
Das A; Singh V; Fleischer DE; Sharma VK
Am J Gastroenterol; 2008 Jun; 103(6):1340-5. PubMed ID: 18510606
[TBL] [Abstract][Full Text] [Related]
14. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors for Metachronous Contralateral Breast Cancer: Implications for Management of the Contralateral Breast.
Marmor S; Portschy PR; Burke EE; Virnig BA; Tuttle TM
Breast J; 2017 May; 23(3):299-306. PubMed ID: 27988977
[TBL] [Abstract][Full Text] [Related]
16. Nomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer: a SEER-Medicare analysis.
Eil R; Diggs BS; Wang SJ; Dolan JP; Hunter JG; Thomas CR
Cancer; 2014 Feb; 120(4):492-8. PubMed ID: 24194477
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes in esophageal cancer patients with a prior cancer.
Pan D; Xu W; Gao X; Yiyang F; Wei S; Zhu G
Medicine (Baltimore); 2021 Feb; 100(7):e24798. PubMed ID: 33607840
[TBL] [Abstract][Full Text] [Related]
18. TNM stage is the most important determinant of survival in metachronous lung cancer.
Lee BE; Port JL; Stiles BM; Saunders J; Paul S; Lee PC; Altorki N
Ann Thorac Surg; 2009 Oct; 88(4):1100-5. PubMed ID: 19766788
[TBL] [Abstract][Full Text] [Related]
19. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis.
Njei B; McCarty TR; Birk JW
J Gastroenterol Hepatol; 2016 Jun; 31(6):1141-6. PubMed ID: 26749521
[TBL] [Abstract][Full Text] [Related]
20. Survival in patients with metachronous second primary lung cancer.
Ha D; Choi H; Chevalier C; Zell K; Wang XF; Mazzone PJ
Ann Am Thorac Soc; 2015 Jan; 12(1):79-84. PubMed ID: 25494009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]